{"database": "lobbying", "table": "lobbying_activities", "rows": [[2349836, "5265b21a-216c-4cab-8ae6-959dfce98db5", "Q3", "MASSACHUSETTS MEDICAL SOCIETY", 23975, "MASSACHUSETTS MEDICAL SOCIETY", 2019, "third_quarter", "PHA", "Prescription Drugs\n\nH.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs Act\n\nH.R. 2700 - Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act\n\nS. 340, H.R. 965 - Creating and Restoring Equal Access to Equivalent Samples Act of 2019\nCREATES Act of 2019\" - promote competition in the market for drugs and biological products by facilitating the timely entry of entry of lower-cost generic and biosimilar versions of those drugs and biological products\n\nH.R. 3 - The Lower Drug Costs Now Act \n\nS. 99, H.R. 448 - Medicare Drug Price Negotiation Act  \n\nH.R. 275 - Medicare Prescription Drug Price Negotiation Act of 2019\n\nAverage Wholesale Price of Pharmaceuticals in Ads - no specific bill\n\nH.R. 2113 Prescription Drug STAR Act - Transparency of pharmaceutical prices across all sectors", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 80000, 0, 0, "2019-10-18T10:31:20.037000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2349836"], "units": {}, "query_ms": 207.5223430292681, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}